Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H6ClNO3 |
InChIKeyIDIQKTSGSIPAFJ-UHFFFAOYSA-N |
CAS Registry65300-74-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 17 Jan 2005 |